TFA Therapeutics (RAJAF) Shares Outstanding (2020 - 2025)

TFA Therapeutics has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $111.1 million in Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) changed 0.0% year-over-year to $111.1 million in Q4 2025; TTM through Dec 2025 was $111.1 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $111.1 million, changed 0.0% from the prior year.
• Shares Outstanding (Entity) was $111.1 million for Q4 2025 at TFA Therapeutics, roughly flat from $111.1 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $111.1 million in Q4 2021, with the low at $111.1 million in Q4 2021.
• Average Shares Outstanding (Entity) over 5 years is $111.1 million, with a median of $111.1 million recorded in 2021.
• The largest YoY upside for Shares Outstanding (Entity) was 0.0% in 2021 against a maximum downside of 0.0% in 2021.
• Over 5 years, Shares Outstanding (Entity) stood at $111.1 million in 2021, then changed by 0.0% to $111.1 million in 2022, then changed by 0.0% to $111.1 million in 2023, then changed by 0.0% to $111.1 million in 2024, then changed by 0.0% to $111.1 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $111.1 million (Q4 2025), $111.1 million (Q4 2024), and $111.1 million (Q4 2023), per Business Quant data.